Profile Core value Main business Legitimacy Social Responsibility
                          Patents Research Direction Technology Strength
                        API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
                        Production management QC Quality System branch factory




                        Products Center
                      Paclitaxel (Semi-synthetic)
                      Paclitaxel (Natural)
                      Docetaxel Anhydrous
                      Docetaxel Trihydrate
                      Irinotecan HCl Trihydrate 99.5%
                      Etoposide USP31
                      Palonosetron Hydrochloride
                        N-1 stage of Paclitaxel and Docetaxel
                        Main Intermediates
                      10-Deacetylbaccatin III
                      Baccatin III
                        Side chain for Paclixel semi-Synthetic
                      (4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
                        Side chain of Docetaxel
                      (4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
                        Side chain for Paclitaxel and Docetaxel
                      Ethyl (2R,3S)-3-Phenylisoserine Ester
                      Your location:Home>>R & D >>Patents

                      Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns three patents as below:

                       One of Irinotecan’s Intermediates & its Preparation method and preparation Method Of Irinotecan
                      Patent Number: ZL 2007 1 004 1525.X
                      Issue Date: Oct. 27, 2010

                       A Synthetic method of Docetaxel
                      Patent Number: ZL 2006 1 0116735.6
                      Issue Date: 30 July, 2008

                       A method of Extracting and Purifying 10- Deacetyl Baccatin III
                      Patent Number: ZL 03 1 29635.1
                      Issue Date: 18 May, 2005

                      Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development.

                      CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
                      HOME About us Products R & D Production and QA Contact us CHINESE